Gilles Edan

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: June 12, 2026

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology

Published: May 05, 2026

Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.

Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 26, 2026

Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.

Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 24, 2026

A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.

A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.

Journal: Revue neurologique

Published: February 22, 2026

Global overview of multiple sclerosis care units: an international cross-sectional survey.

Global overview of multiple sclerosis care units: an international cross-sectional survey.

Journal: Frontiers in neurology

Published: February 17, 2026

Performances of experts and automated methods on new multiple sclerosis lesions detection: insights from the MSSeg2 challenge.

Performances of experts and automated methods on new multiple sclerosis lesions detection: insights from the MSSeg2 challenge.

Journal: Scientific reports

Published: November 14, 2025

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: July 21, 2025

Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.

Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.

Journal: Neurology

Published: July 17, 2025

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Journal: Neurology

Published: July 16, 2025

PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.

PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.

Journal: JAMIA open

Published: June 02, 2025

Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysis.

Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysis.

Journal: Multiple sclerosis and related disorders

Published: May 12, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026